Ken Iseki
Impact in
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism
- Phytochemicals and Antioxidant Activities
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
- Oncology 117
- Drug Transport and Resistance Mechanisms 102
-
- Cancer therapeutics and mechanisms 11
- Co-authors
- Masaki Kobayashi (135 shared papers)Takeshi Hirano (70 shared papers)Shirou Itagaki (64 shared papers)Mitsuru Sugawara (66 shared papers)Jiro Ogura (38 shared papers)Katsumi Miyazaki (66 shared papers)Katsuya Narumi (54 shared papers)Yuki Sato (8 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (31 papers)Journal of Pharmacy and Pharmacology (26 papers)Drug Metabolism and Pharmacokinetics (18 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (17 papers)International Journal of Pharmaceutics (13 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ken Iseki
265 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Biochemistry 463
- Pharmaceutical Science 436
- Biochemistry 404
- Oncology 1.5k
- Pharmacology 813
Countries citing papers authored by Ken Iseki
This map shows the geographic impact of Ken Iseki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Iseki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Iseki more than expected).
Fields of papers citing papers by Ken Iseki
This network shows the impact of papers produced by Ken Iseki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Iseki. The network helps show where Ken Iseki may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Iseki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid Hit paper breakdown → | 2010 | 794 |
| 2 | 2000 | 140 | |
| 3 | 1999 | 110 | |
| 4 | 2006 | 105 | |
| 5 | 2013 | 93 | |
| 6 | 2008 | 78 | |
| 7 | 2014 | 76 | |
| 8 | 2001 | 74 | |
| 9 | 2006 | 64 | |
| 10 | 2006 | 54 | |
| 11 | 2006 | 51 | |
| 12 | 2008 | 50 | |
| 13 | 2015 | 50 | |
| 14 | 2003 | 48 | |
| 15 | 2012 | 48 | |
| 16 | 2011 | 48 | |
| 17 | 2007 | 47 | |
| 18 | 2021 | 45 | |
| 19 | 2008 | 45 | |
| 20 | 1989 | 45 |
About Ken Iseki
Ken Iseki is a scholar working on Oncology, Molecular Biology, Pharmacology, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 273 papers that have together received 5.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (102 papers), Pharmacological Effects and Toxicity Studies (38 papers), Antibiotics Pharmacokinetics and Efficacy (38 papers), Amino Acid Enzymes and Metabolism (27 papers), Metabolism and Genetic Disorders (14 papers), Advanced Drug Delivery Systems (13 papers), Drug Solubulity and Delivery Systems (11 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Biochemistry (463 citations), Pharmaceutical Science (436 citations), Biochemistry (404 citations), Oncology (1.5k citations) and Pharmacology (813 citations). Ken Iseki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masaki Kobayashi, Takeshi Hirano, Shirou Itagaki, Mitsuru Sugawara, Jiro Ogura, Katsumi Miyazaki, Katsuya Narumi, Yuki Sato, Ayako Furugen and Michiya Kobayashi. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Journal of Pharmacy and Pharmacology, Drug Metabolism and Pharmacokinetics, Biochimica et Biophysica Acta (BBA) - Biomembranes and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.